Centessa Pharmaceuticals PLC ADR (CNTA) — Long-term Investment Intensity
Centessa Pharmaceuticals PLC ADR (CNTA) has a Long-term Investment Intensity of 40.1% as of March 2026. Long-term investments of $257.12 Million represent 40.1% of total assets of $641.76 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Centessa Pharmaceuticals PLC ADR liquid asset ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Centessa Pharmaceuticals PLC ADR Long-term Investment Intensity (2025–2025)
This chart shows how Centessa Pharmaceuticals PLC ADR's Long-term Investment Intensity has evolved across 1 annual periods from 2025 to 2025. As of March 2026, the intensity stands at 40.1%, reflecting long-term investments of $257.12 Million against total assets of $641.76 Million USD. For the complete balance sheet picture, see Centessa Pharmaceuticals PLC ADR balance sheet assets.
Annual Long-term Investment Intensity for Centessa Pharmaceuticals PLC ADR (2025–2025)
The table below presents the year-by-year Long-term Investment Intensity for Centessa Pharmaceuticals PLC ADR from 2025 to 2025, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read CNTA total liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 41.1% | $282.55 Million | $687.50 Million | — |